EV-302: Impact of Enfortumab Vedotin + Pembrolizumab in Metastatic Bladder Cancer

News
Video

Shifting their focus to metastatic bladder cancer, the Oncology Brothers and Rana McKay, MD, reflect on data from EV-302 and consider how enfortumab vedotin + pembrolizumab has shifted the treatment landscape.

Related Videos
Experts on GU Cancer
Experts on GU Cancer
Experts on GU Cancer
Expert on mUC
Expert on mUC
Expert on mUC
Expert on mUC
Expert on mUC
Related Content